Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Free Cash Flow (Quarterly): -143.75M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -143.75M |
| June 30, 2023 | -132.12M |
| March 31, 2023 | -190.45M |
| December 31, 2022 | -129.61M |
| September 30, 2022 | -139.05M |
| June 30, 2022 | -145.15M |
| March 31, 2022 | -161.61M |
| December 31, 2021 | -140.63M |
| September 30, 2021 | -49.04M |
| June 30, 2021 | -97.40M |
| March 31, 2021 | -111.52M |
| December 31, 2020 | -77.93M |
| September 30, 2020 | -78.20M |
| June 30, 2020 | -60.54M |
| March 31, 2020 | -59.23M |
| December 31, 2019 | -43.23M |
| September 30, 2019 | -33.02M |
| June 30, 2019 | -38.54M |
| March 31, 2019 | -34.48M |
| December 31, 2018 | -20.88M |
| September 30, 2018 | -20.21M |
| June 30, 2018 | -21.18M |
| March 31, 2018 | -7.948M |
| December 31, 2017 | -13.77M |
| September 30, 2017 | -15.09M |
| Date | Value |
|---|---|
| June 30, 2017 | -17.70M |
| March 31, 2017 | -18.23M |
| December 31, 2016 | -16.26M |
| September 30, 2016 | -18.32M |
| June 30, 2016 | -16.64M |
| March 31, 2016 | -17.00M |
| December 31, 2015 | -16.06M |
| September 30, 2015 | -15.87M |
| June 30, 2015 | -9.318M |
| March 31, 2015 | -9.793M |
| December 31, 2014 | -8.653M |
| September 30, 2014 | -9.673M |
| June 30, 2014 | -6.008M |
| March 31, 2014 | -8.80M |
| December 31, 2013 | -7.72M |
| September 30, 2013 | -5.235M |
| June 30, 2013 | -9.274M |
| March 31, 2013 | -7.43M |
| December 31, 2012 | -5.349M |
| September 30, 2012 | -4.201M |
| June 30, 2012 | -2.867M |
| March 31, 2012 | -4.463M |
| December 31, 2011 | -3.660M |
| September 30, 2011 | -2.447M |
| June 30, 2011 | -2.319M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-190.45M
Minimum
Mar 2023
-33.02M
Maximum
Sep 2019
-101.72M
Average
-104.46M
Median
Free Cash Flow (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.55B |
| Karuna Therapeutics Inc (DELISTED) | -111.86M |
| Puma Biotechnology Inc | 11.25M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |